Viridian Therapeutics, Inc.\de
VRDN
Revenue
4.78M
▲3.59M▲301.34%
3 Months ChangeAssets
585.66M
▼-44.72M▼-7.09%
3 Months ChangeLiabilities
56.33M
▲8.47M▲17.71%
3 Months ChangeFree Cash Flow
-45.22M
▲16.87M▲27.16%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-12
Form 8-K
ID: 0001193125-24-218131
2024-09-10
Form 8-K
ID: 0001193125-24-216321
2024-08-08
Form 8-K
ID: 0001193125-24-196513
2024-08-08
Form 10-Q
ID: 0001590750-24-000019
2024-07-15
Form 8-K
ID: 0001193125-24-178820
2024-06-20
Form 8-K
ID: 0001193125-24-164461
2024-05-08
Form 10-Q
ID: 0001590750-24-000012
2024-05-08
Form 8-K
ID: 0001193125-24-133770
2024-04-16
Form 8-K
ID: 0001193125-24-097728
2024-02-27
Form 8-K
ID: 0001193125-24-047916